Development and verification of a personalized immune prognostic feature in breast cancer.

ABSTRACT:

Impact statement

Breast cancer is among the highest prevalent malignant tumors worldwide with a low survival ratio. Immune-related genes have great potential as prognostic indicator in many types of tumors. Therefore, we have attempted to develop immune-related gene markers to enhance the prognosis of breast cancer. 17-IRGPs signature was constructed as a newly developed prognostic indicator to predict the survival of BC patients.

SUBMITTER: Wang H 

PROVIDER: S-EPMC7437380 | biostudies-literature | 2020 Aug

REPOSITORIES: biostudies-literature